NAVAMEDIC (NAVA.OL) Stock Income Statement
OSL:NAVA - Euronext Oslo - NO0010205966 - Common Stock - Currency: NOK
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 531.44M | 512.00M | 382.13M | 278.40M | 209.90M | |||
| Cost Of Goods | 322.56M | 312.94M | 218.62M | 166.70M | 139.50M | |||
| Gross Profit | 208.88M | 199.05M | 163.52M | 111.70M | 70.30M | |||
| Operating Expenses | 177.08M | 159.41M | 119.08M | 100.30M | 75.30M | |||
| Selling, General, and Administrative Expenses | N/A | 114.88M | 48.09M | 44.50M | 32.60M | |||
| Operating Income | 31.80M | 39.64M | 44.44M | 11.50M | -4.90M | |||
| Interest Income/Expense | -18.98M | -6.32M | -8.65M | -7.20M | -10.50M | |||
| Other Income/Expense | N/A | -6.43M | -2.80M | -1.90M | -1.10M | |||
| Non Recurring Items | -7.66M | -16.06M | 9.51M | N/A | N/A | |||
| Income Before Taxes | 5.16M | 10.83M | 42.51M | 2.40M | -16.60M | |||
| Income Tax | 3.87M | 7.53M | 13.07M | 1.70M | -100.00K | |||
| Net Income | 1.29M | 3.30M | 29.43M | 600.00K | -16.50M | |||
| EBITDA | N/A | 51.57M | 51.69M | 18.22M | -1.24M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.07 | 0.19 | 1.71 | 0.04 | -1.14 | |||
| Statistics | ||||||||
| Gross Profit Margin | 39.30% | 38.88% | 42.79% | 40.12% | 33.49% | |||
| Profit Margin | 0.24% | 0.65% | 7.70% | 0.22% | -7.86% | |||
| Operating Profit Margin | 5.98% | 7.74% | 11.63% | 4.13% | -2.33% | |||
All data in NOK